Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6896)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2014 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou HB, Hu JY, Hu HP. Hepatitis B virus infection and intrahepatic cholangiocarcinoma. World J Gastroenterol 2014; 20(19): 5721-5729 [PMID: 24914333 DOI: 10.3748/wjg.v20.i19.5721] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i19/5721.htm |
| Number | Citing Articles |
| 1 |
Cheng Lou, Tong Bai, Le-Wei Bi, Ying-Tang Gao, Zhi Du. Negative impact of hepatitis B surface seroclearance on prognosis of hepatitis B-related primary liver cancer. World Journal of Clinical Cases 2018; 6(8): 192-199 doi: 10.12998/wjcc.v6.i8.192
|
| 2 |
Ruben R. Plentz, Nisar P. Malek. Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Practice & Research Clinical Gastroenterology 2015; 29(2): 245 doi: 10.1016/j.bpg.2015.02.001
|
| 3 |
Linghao Zhao, Yuyouye Wang, Tao Tian, Xinjie Rao, Wei Dong, Jinmin Zhang, Yuan Yang, Qifei Tao, Fang Peng, Chenhang Shen, Songbo Wang, Hui Liu, Xi Zeng, Weiping Zhou. Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma. Hepatology International 2022; 16(6): 1339 doi: 10.1007/s12072-022-10419-3
|
| 4 |
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. International Journal of Molecular Sciences 2022; 23(21): 13612 doi: 10.3390/ijms232113612
|
| 5 |
Sasan Mosadeghi, Benny Liu, Taft Bhuket, Robert J. Wong. Sex‐specific and race/ethnicity‐specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000–2011 Surveillance, Epidemiology and End Results registry. Hepatology Research 2016; 46(7): 669 doi: 10.1111/hepr.12605
|
| 6 |
Yi Wei, Feifei Gao, Dandan Zheng, Zixing Huang, Min Wang, Fubi Hu, Chenyang Chen, Ting Duan, Jie Chen, Likun Cao, Bin Song. Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging. Oncotarget 2018; 9(8): 7975 doi: 10.18632/oncotarget.23807
|
| 7 |
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology 2016; 13(5): 261 doi: 10.1038/nrgastro.2016.51
|
| 8 |
Deborah Clark. Painless obstructive jaundice leading to diagnosis of extrahepatic cholangiocarcinoma: a case study and review. Gastrointestinal Nursing 2019; 17(Sup10): S22 doi: 10.12968/gasn.2019.17.Sup10.S22
|
| 9 |
Zimin Song, Shuirong Lin, Xiwen Wu, Xiaoxue Ren, Yifan Wu, Haoxiang Wen, Baifeng Qian, Haozhong Lin, Yihao Huang, Chenfeng Zhao, Nian Wang, Yan Huang, Baogang Peng, Xiaoxing Li, Hong Peng, Shunli Shen. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes. Hepatology International 2023; 17(5): 1300 doi: 10.1007/s12072-023-10556-3
|
| 10 |
Martha M. Kirstein, Arndt Vogel. Epidemiology and Risk Factors of Cholangiocarcinoma. Visceral Medicine 2016; 32(6): 395 doi: 10.1159/000453013
|
| 11 |
Vivek Bhakta Mathema, Kesara Na-Bangchang. Current Insights on Cholangiocarcinoma Research: a Brief Review. Asian Pacific Journal of Cancer Prevention 2015; 16(4): 1307 doi: 10.7314/APJCP.2015.16.4.1307
|
| 12 |
Teng-Yu Lee, Yao-Chun Hsu, Shi-Hang Yu, Jaw-Town Lin, Ming-Shiang Wu, Chun-Ying Wu. Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology 2018; 16(6): 947 doi: 10.1016/j.cgh.2017.09.031
|
| 13 |
Lian-Yuan Tao, Xiao-Dong He, Dian-Rong Xiu. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology 2016; 40(6): 682 doi: 10.1016/j.clinre.2016.04.001
|
| 14 |
Markus Zeisbrich, Sarah Wendel, Stephanie Finzel, Reinhard E. Voll, Nils Venhoff. Favourable outcome of acute hepatitis E infection in patients with ANCA-associated vasculitis. Orphanet Journal of Rare Diseases 2022; 17(1) doi: 10.1186/s13023-022-02586-1
|
| 15 |
Teresa Catalano, Federico Selvaggi, Diana Liberata Esposito, Roberto Cotellese, Gitana Maria Aceto. Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. Microorganisms 2023; 11(7): 1632 doi: 10.3390/microorganisms11071632
|
| 16 |
Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0712-x
|
| 17 |
Junmin Song, Yang Li, Christopher L. Bowlus, GuoXiang Yang, Patrick S. C. Leung, M. Eric Gershwin. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review. Clinical Reviews in Allergy & Immunology 2020; 58(1): 134 doi: 10.1007/s12016-019-08764-7
|
| 18 |
Kelly J. Lafaro, David Cosgrove, Jean-Francois H. Geschwind, Ihab Kamel, Joseph M. Herman, Timothy M. Pawlik. Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/860861
|
| 19 |
Jason Ho, Steven A. Curley. Gastrointestinal Malignancies. Cancer Treatment and Research 2016; : 121 doi: 10.1007/978-3-319-34244-3_7
|
| 20 |
Thanachote Kamalapirat, Teerapat Ungtrakul. Reply to ‘Consider more about risk scores for predicting hepatocellular carcinoma in patients with chronic hepatitis B’. Journal of Viral Hepatitis 2021; 28(10): 1501 doi: 10.1111/jvh.13566
|
| 21 |
Nikolaos Fragkou, Lazaros Sideras, Panteleimon Panas, Christos Emmanouilides, Emmanouil Sinakos. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?. World Journal of Gastroenterology 2021; 27(27): 4252-4275 doi: 10.3748/wjg.v27.i27.4252
|
| 22 |
Cortlandt M. Sellers, Johannes Uhlig, Johannes M. Ludwig, Stacey M. Stein, Hyun S. Kim. Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease. Cancer Medicine 2019; 8(13): 5916 doi: 10.1002/cam4.2373
|
| 23 |
Anusha Vakiti, Min Ho Cho, Wen Lee, John J Liang, Alexander T Lalos, Dawn A Fishbein. Use of direct-acting antivirals for hepatitis C viral infection and association with intrahepatic cholangiocarcinoma: Is there a linkage?. Journal of Oncology Pharmacy Practice 2019; 25(7): 1743 doi: 10.1177/1078155218800147
|
| 24 |
Jung Woong Seo, Byung Soo Kwan, Young Koog Cheon, Tae Yoon Lee, Chan Sup Shim, So Young Kwon, Won Hyeok Choe, Byung Chul Yoo, Jeong Min Yoon, Jung Hoon Lee. Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma. The Korean Journal of Internal Medicine 2020; 35(3): 566 doi: 10.3904/kjim.2018.062
|
| 25 |
Teresa Pollicino, Cristina Musolino, Carlo Saitta, Gianluca Tripodi, Marika Lanza, Giuseppina Raffa, Francesca Casuscelli di Tocco, Chiara Raggi, Maria Consiglia Bragazzi, Adalberto Barbera, Giuseppe Navarra, Pietro Invernizzi, Domenico Alvaro, Giovanni Raimondo. Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma. Oncotarget 2019; 10(39): 3931 doi: 10.18632/oncotarget.27002
|
| 26 |
Zetao Yu, Qingqiang Ni, Hongtao Jia, Hengjun Gao, Faji Yang, Huaqiang Zhu, Fangfeng Liu, Jianlu Wang, Xu Zhou, Hong Chang, Jun Lu. Prognostic analysis of radical resection for iCCAphl and iCCApps: A retrospective cohort study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.992606
|
| 27 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
|
| 28 |
Wei Zhao, Shizhong Yang, Jianfeng Chen, Jing Zhao, Jiahong Dong. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway. Life Sciences 2018; 210: 224 doi: 10.1016/j.lfs.2018.09.009
|
| 29 |
Qiushi Yu, Zhengqing Lei, Weihu Ma, Facai Yang, Haolan Tang, Qianru Xiao, Xuewu Tang, Anfeng Si, Pinghua Yang, Nan Zhou, Zhangjun Cheng. Postoperative Prognosis of Non-alcoholic Fatty Liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis. Journal of Gastrointestinal Surgery 2023; 27(11): 2403 doi: 10.1007/s11605-023-05794-7
|
| 30 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 605 doi: 10.1007/978-3-319-26956-6_31
|
| 31 |
Minjie Wang, Yuting Wang, Xiaoshuang Feng, Ruijun Wang, Yanmei Wang, Hongmei Zeng, Jun Qi, Hong Zhao, Ni Li, Jianqiang Cai, Chunfeng Qu. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center. International Journal of Infectious Diseases 2017; 65: 15 doi: 10.1016/j.ijid.2017.09.003
|
| 32 |
Deyao Zhang, Huilan Zeng, Yangxun Pan, Yumo Zhao, Xin Wang, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Zhongguo Zhou, Li Xu, Minshan Chen, Dandan Hu. Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery. Journal of Personalized Medicine 2022; 12(12): 2041 doi: 10.3390/jpm12122041
|